Bev Shea – OMERACT

Safety – OMERACT

Dr. Lisa Christopher, MD, Baltimore, MD, Rheumatologist

Myositis – OMERACT

Towards consensus in defining and handling contextual factors within rheumatology trials: An initial qualitative study from an OMERACT working group

PDF) THU0303 THE Omeract Core Domain Set for Clinical Trials in Behçet's Syndrome

2018 GRAPPA Trainees Symposium Abstracts Presented in Toronto, 2019

Myositis – OMERACT

Safety – OMERACT

About us

Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies

Late-Stage Knee and Hip Osteoarthritis Composite Measure – OMERACT

Mary Cowern - Head of Nation - Versus Arthritis

Myositis – OMERACT